Gene therapy for spinal muscular atrophy: the Qatari experienceHossamaldein Gaber Ali, Tawfeg Ben‐Omran, Mariam AlMulla et al.|Gene Therapy|2021Cited by 53
A founder <scp>RAB27A</scp> variant causes Griscelli syndrome type 2 with phenotypic heterogeneity in Qatari familiesReem Alsulaiman, Tawfeg Ben‐Omran, Amna Othman et al.|American Journal of Medical Genetics Part A|2020Cited by 18
Expanding on the phenotypic spectrum of<scp>Woodhouse‐Sakati</scp>syndrome due to founder pathogenic variant in<scp><i>DCAF17</i></scp>: Report of 58 additional patients from Qatar and literature reviewRehab Ali, Tawfeg Ben‐Omran, Nader Al‐Dewik et al.|American Journal of Medical Genetics Part A|2021Cited by 16
Clinical and Molecular Characterization of Qatari Patients with Inherited DysfibrinogenemiaAmna Gameil, Reem Alsulaiman, Hajer Al-Mulla et al.|Blood|2021Cited by 0